Internal Medicine, Endocrinology, Diabetes, & Metabolism · Rochester, NY
NPI
1093030553
Since 2010
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
224 Alexander St Ste 200
Rochester, NY, 14607
Phone (585) 922-8400
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
721 services
Medicare patients, 2024
333
Average age 70
Drug cost, 2024
$5.4M
8,533 prescriptions
Company payments, 2025
$53K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael W Quartuccio was code 99214 (office e&m - established), 348 times for 244 patients. In total Michael W Quartuccio billed 721 services in 9 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 348 | 244 | $69.90 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 128 | 104 | $12.45 | $1,593 |
| 95251 Test - Miscellaneous | Office | 120 | 73 | $26.82 | $3,218 |
| 99204 Office E&M - New | Office | 40 | 40 | $98.96 | $3,958 |
| 99231 Hospital E&M - Subsequent | Facility | 29 | 16 | $39.73 | $1,152 |
| 99213 Office E&M - Established | Office | 24 | 23 | $45.07 | $1,082 |
| 99223 Hospital E&M - Initial | Facility | 15 | 13 | $139.21 | $2,088 |
By year: 2022 $34K for 512 services; 2023 $35K for 580 services; 2024 $39K for 721 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael W Quartuccio prescribed most often to Medicare patients was Ozempic (Semaglutide), with 980 prescriptions and refills. In total Michael W Quartuccio wrote 8,533 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 980 | 1,635 | 262 | $1.5M |
| Levothyroxine Sodium Generic | 639 | 1,748 | 203 | $10K |
| Trulicity Dulaglutide | 424 | 612 | 112 | $582K |
| Mounjaro Tirzepatide | 388 | 443 | 100 | $459K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 387 | 1,018 | 152 | $61K |
| Metformin Hcl Er Metformin Hcl | 364 | 918 | 128 | $6,666 |
| Jardiance Empagliflozin | 358 | 883 | 111 | $497K |
| Metformin Hcl Generic | 349 | 913 | 107 | $4,139 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 239 | 610 | 111 | $99K |
| Methimazole Generic | 211 | 515 | 59 | $2,415 |
| Atorvastatin Calcium Generic | 176 | 501 | 59 | $2,645 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 168 | 418 | 71 | $19K |
| Glipizide Generic | 166 | 402 | 51 | $1,811 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 164 | 288 | 38 | $185K |
| Rosuvastatin Calcium Generic | 159 | 412 | 48 | $2,281 |
Brand drugs: 4,764 claims; generic drugs: 3,045 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael W Quartuccio $53K ($53K in general payments such as food, travel and fees) from 4 companies. The largest payer was Novo Nordisk Inc with $51K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.